Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Rotator Cuff Tears

Stopped early · Phase 1

Conditions studied: Rotator Cuff Tear

In brief

The purpose of this study is to further define the optimal non-surgical treatment strategy for partial thickness rotator cuff tears. The specific aim of this study is to determine the outcomes of treatment of partial thickness rotator cuff tears with corticosteroid or platelet rich plasma (PRP). Subjects with partial thickness rotator cuff tears will be randomized to receive an injection of PRP or corticosteroid. Shoulder function and tendon healing will be evaluated using the patient surveys as well as ultrasound. Subjects will be followed for one year to determine the outcomes for each treatment. The hypothesis is that there is no difference in healing rate or functional outcomes in patients treated with corticosteroid injections vs. PRP injections for the treatment of partial thickness rotator cuff tears.

Key facts

Study ID

NCT01688362

Run by

University of North Carolina, Chapel Hill

People needed

12

Starts

2012-11-01

Expected to finish

2014-05-01

Last updated by the study team

2017-04-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Shoulder pain for at least two weeks.
• Partial thickness articular sided rotator cuff tear diagnosed by MRI and musculoskeletal ultrasound.

You may not qualify if…

• Prior surgery to the injured shoulder
• Full thickness rotator cuff tear
• Pregnancy
• Cancer
• Current treatment with anticoagulation medication
• Steroid injection in the past 6 months in the injured shoulder
• Prior PRP treatment to the injured shoulder

Where it is running

• University of North Carolina Department of Orthopaedics — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.